Jiutian Chemical Group Limited (SGX:C8R)
0.0240
+0.0010 (4.35%)
At close: Apr 28, 2026
Jiutian Chemical Group Revenue
In the year 2025, Jiutian Chemical Group had annual revenue of 109.71M CNY with 116.96% growth. Jiutian Chemical Group had revenue of 13.29M in the quarter ending December 31, 2025, a decrease of -177.87%.
Revenue
109.71M CNY
Revenue Growth
+116.96%
P/S Ratio
2.37
Revenue / Employee
n/a
Employees
n/a
Market Cap
47.72M SGD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.71M | 59.14M | 116.96% |
| Dec 31, 2024 | 50.57M | -548.00M | -91.55% |
| Dec 31, 2023 | 598.56M | -1.84B | -75.42% |
| Dec 31, 2022 | 2.43B | 261.53M | 12.03% |
| Dec 31, 2021 | 2.17B | 1.03B | 89.60% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mencast Holdings | 46.34M |
| Wong Fong Industries | 76.51M |
| LMS Compliance | 10.66M |
| KOP Limited | 19.59M |
| UG Healthcare Corporation | 146.09M |
| 9R Limited | 12.46M |
| Lincotrade & Associates Holdings | 93.26M |
| Singapore Institute of Advanced Medicine Holdings | 15.93M |